Bellevue Group’s Evolent Health EVH Stock Holding History

Bellevue Group’s Portfolio EVH Stock Details EVH Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-614,337	Closed	-$5.82M	–	148
2025 Q1	$5.82M	Sell	614,337 -499,321	-45%	-$4.73M	0.13%	82
2024 Q4	$12.5M	Sell	1,113,658 -1,556,392	-58%	-$17.5M	0.24%	74
2024 Q3	$75.5M	Buy	2,670,050 +1,000,215	+60%	+$28.3M	1.22%	24
2024 Q2	$31.9M	Buy	1,669,835 +186,739	+13%	+$3.57M	0.52%	55
2024 Q1	$48.6M	Sell	1,483,096 -893,896	-38%	-$29.3M	0.74%	41
2023 Q4	$78.5M	Sell	2,376,992 -1,300,123	-35%	-$42.9M	1.2%	22
2023 Q3	$100M	Buy	3,677,115 +228,793	+7%	+$6.23M	1.61%	16
2023 Q2	$104M	Buy	3,448,322 +1,257,175	+57%	+$38.1M	1.49%	19
2023 Q1	$71.1M	Buy	2,191,147 +207,494	+10%	+$6.73M	1.03%	33
2022 Q4	$55.7M	Buy	1,983,653 +114,598	+6%	+$3.22M	0.74%	43
2022 Q3	$67.2M	Sell	1,869,055 -149,466	-7%	-$5.37M	0.96%	37
2022 Q2	$62M	Sell	2,018,521 -593,742	-23%	-$18.2M	0.88%	38
2022 Q1	$84.4M	Buy	2,612,263 +2,970	+0.1%	+$95.9K	0.98%	36
2021 Q4	$72.2M	Sell	2,609,293 -423,385	-14%	-$11.7M	0.74%	46
2021 Q3	$94M	Sell	3,032,678 -605,733	-17%	-$18.8M	0.95%	38
2021 Q2	$76.8M	Buy	3,638,411 +109,864	+3%	+$2.32M	0.75%	43
2021 Q1	$71.3M	Buy	3,528,547 +379,436	+12%	+$7.66M	0.75%	44
2020 Q4	$50.5M	Sell	3,149,111 -124,214	-4%	-$1.99M	0.58%	53
2020 Q3	$40.6M	Sell	3,273,325 -1,755,038	-35%	-$21.8M	0.56%	51
2020 Q2	$35.8M	Buy	5,028,363 +447,905	+10%	+$3.19M	0.51%	50
2020 Q1	$24.9M	Buy	4,580,458 +1,031,845	+29%	+$5.6M	0.48%	55
2019 Q4	$32.1M	Buy	3,548,613 +523,591	+17%	+$4.74M	0.51%	51
2019 Q3	$21.8M	Buy	3,025,022 +676,022	+29%	+$4.86M	0.4%	54
2019 Q2	$18.7M	Buy	2,349,000 +940,763	+67%	+$7.48M	0.32%	59
2019 Q1	$17.7M	Buy	1,408,237 +1,362,967	+3,011%	+$17.1M	0.97%	32
2018 Q4	$903K	Buy	+45,270	New	+$903K	0.06%	119